Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

14-3-3sigma and p21 synergize to determine DNA damage response following Chk2 inhibition.

Meng S, Arbit T, Veeriah S, Mellinghoff IK, Fang F, Vivanco I, Rohle D, Chan TA.

Cell Cycle. 2009 Jul 15;8(14):2238-46. Epub 2009 Jul 12.

PMID:
19502805
2.

Cooperative effect of p21Cip1/WAF-1 and 14-3-3sigma on cell cycle arrest and apoptosis induction by p14ARF.

Hemmati PG, Normand G, Gillissen B, Wendt J, Dörken B, Daniel PT.

Oncogene. 2008 Dec 4;27(53):6707-19. doi: 10.1038/onc.2008.193. Epub 2008 Sep 22.

PMID:
18806827
3.

Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.

Lossaint G, Besnard E, Fisher D, Piette J, Dulić V.

Oncogene. 2011 Oct 13;30(41):4261-74. doi: 10.1038/onc.2011.135. Epub 2011 May 2.

PMID:
21532626
4.

Elevated cyclin G2 expression intersects with DNA damage checkpoint signaling and is required for a potent G2/M checkpoint arrest response to doxorubicin.

Zimmermann M, Arachchige-Don AS, Donaldson MS, Dallapiazza RF, Cowan CE, Horne MC.

J Biol Chem. 2012 Jun 29;287(27):22838-53. doi: 10.1074/jbc.M112.376855. Epub 2012 May 15.

5.

The p53-p21WAF1 checkpoint pathway plays a protective role in preventing DNA rereplication induced by abrogation of FOXF1 function.

Lo PK, Lee JS, Sukumar S.

Cell Signal. 2012 Jan;24(1):316-24. doi: 10.1016/j.cellsig.2011.09.017. Epub 2011 Sep 22.

6.

Stalled replication induces p53 accumulation through distinct mechanisms from DNA damage checkpoint pathways.

Ho CC, Siu WY, Lau A, Chan WM, Arooz T, Poon RY.

Cancer Res. 2006 Feb 15;66(4):2233-41.

7.

Bendamustine induces G2 cell cycle arrest and apoptosis in myeloma cells: the role of ATM-Chk2-Cdc25A and ATM-p53-p21-pathways.

Gaul L, Mandl-Weber S, Baumann P, Emmerich B, Schmidmaier R.

J Cancer Res Clin Oncol. 2008 Feb;134(2):245-53. Epub 2007 Jul 25.

PMID:
17653574
8.

The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe.

Castedo M, Perfettini JL, Roumier T, Yakushijin K, Horne D, Medema R, Kroemer G.

Oncogene. 2004 May 27;23(25):4353-61.

PMID:
15048074
9.

Chromosomal breaks during mitotic catastrophe trigger γH2AX-ATM-p53-mediated apoptosis.

Imreh G, Norberg HV, Imreh S, Zhivotovsky B.

J Cell Sci. 2011 Sep 1;124(Pt 17):2951-63. doi: 10.1242/jcs.081612. Erratum in: J Cell Sci. 2017 Sep 21;:. J Cell Sci. 2016 May 1;129(9):1950.

10.

Topoisomerase inhibitor coralyne photosensitizes DNA, leading to elicitation of Chk2-dependent S-phase checkpoint and p53-independent apoptosis in cancer cells.

Patro BS, Maity B, Chattopadhyay S.

Antioxid Redox Signal. 2010 Apr 15;12(8):945-60. doi: 10.1089/ars.2009.2508.

PMID:
19922265
11.

Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteins.

Lee MH, Lozano G.

Semin Cancer Biol. 2006 Jun;16(3):225-34. Epub 2006 Apr 6. Review.

PMID:
16697215
12.

Phosphorylated Hsp27 activates ATM-dependent p53 signaling and mediates the resistance of MCF-7 cells to doxorubicin-induced apoptosis.

Xu Y, Diao Y, Qi S, Pan X, Wang Q, Xin Y, Cao X, Ruan J, Zhao Z, Luo L, Liu C, Yin Z.

Cell Signal. 2013 May;25(5):1176-85. doi: 10.1016/j.cellsig.2013.01.017. Epub 2013 Jan 26.

PMID:
23357534
13.

DNA damage-induced activation of p53 by the checkpoint kinase Chk2.

Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, Yoshida H, Liu D, Elledge SJ, Mak TW.

Science. 2000 Mar 10;287(5459):1824-7.

14.

Chk1, but not Chk2, is involved in the cellular response to DNA damaging agents: differential activity in cells expressing or not p53.

Carrassa L, Broggini M, Erba E, Damia G.

Cell Cycle. 2004 Sep;3(9):1177-81. Epub 2004 Sep 13.

PMID:
15326376
15.

Widdrol activates DNA damage checkpoint through the signaling Chk2-p53-Cdc25A-p21-MCM4 pathway in HT29 cells.

Yun HJ, Hyun SK, Park JH, Kim BW, Kwon HJ.

Mol Cell Biochem. 2012 Apr;363(1-2):281-9. doi: 10.1007/s11010-011-1180-z. Epub 2011 Dec 11.

PMID:
22160829
16.

14-3-3sigma is a p53-regulated inhibitor of G2/M progression.

Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler KW, Vogelstein B.

Mol Cell. 1997 Dec;1(1):3-11.

17.

14-3-3sigma mediation of cell cycle progression is p53-independent in response to insulin-like growth factor-I receptor activation.

Zhang Y, Karas M, Zhao H, Yakar S, LeRoith D.

J Biol Chem. 2004 Aug 13;279(33):34353-60. Epub 2004 Jun 8.

18.

Chromium-mediated apoptosis: involvement of DNA-dependent protein kinase (DNA-PK) and differential induction of p53 target genes.

Hill R, Leidal AM, Madureira PA, Gillis LD, Waisman DM, Chiu A, Lee PW.

DNA Repair (Amst). 2008 Sep 1;7(9):1484-99. doi: 10.1016/j.dnarep.2008.05.007. Epub 2008 Jul 7. Erratum in: DNA Repair (Amst). 2013 Oct;12(10):870.

PMID:
18602874
19.

Rsf-1, a chromatin remodeling protein, induces DNA damage and promotes genomic instability.

Sheu JJ, Guan B, Choi JH, Lin A, Lee CH, Hsiao YT, Wang TL, Tsai FJ, Shih IeM.

J Biol Chem. 2010 Dec 3;285(49):38260-9. doi: 10.1074/jbc.M110.138735. Epub 2010 Oct 5.

20.

p14ARF activates a Tip60-dependent and p53-independent ATM/ATR/CHK pathway in response to genotoxic stress.

Eymin B, Claverie P, Salon C, Leduc C, Col E, Brambilla E, Khochbin S, Gazzeri S.

Mol Cell Biol. 2006 Jun;26(11):4339-50.

Supplemental Content

Support Center